Tesar V - Search Results

1

Treatment of proliferative lupus nephritis: a slowly changing landscape.

Tesar V, Hruskova Z. Tesar V, et al. Nat Rev Nephrol. 2011 Feb;7(2):96-109. doi: 10.1038/nrneph.2010.170. Epub 2010 Dec 21. Nat Rev Nephrol. 2011. PMID: 21173789 Review.

2

Soluble cytokine receptors in renal vasculitis and lupus nephritis.

Tesar V, Jirsa M Jr, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J. Tesar V, et al. Med Sci Monit. 2002 Jan;8(1):BR24-9. Med Sci Monit. 2002. PMID: 11782670

3

Antiphospholipid antibodies in patients with lupus nephritis.

Fialová L, Zima T, Tesar V, Mikulíková L, Malbohan IM, Merta M, Certíková V. Fialová L, et al. Among authors: tesar v. Ren Fail. 2003 Sep;25(5):747-58. doi: 10.1081/jdi-120024290. Ren Fail. 2003. PMID: 14575283 Free article.

4

Treatment of lupus nephritis with cyclosporine - an outcome analysis.

Rihova Z, Vankova Z, Maixnerova D, Dostal C, Jancova E, Honsova E, Merta M, Rysava R, Tesar V. Rihova Z, et al. Among authors: tesar v. Kidney Blood Press Res. 2007;30(2):124-8. doi: 10.1159/000101448. Epub 2007 Mar 30. Kidney Blood Press Res. 2007. PMID: 17396037 Clinical Trial.

5

Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.

Kazderova M, Jancova E, Rysava R, Merta M, Tesar V. Kazderova M, et al. Among authors: tesar v. Arch Med Res. 2008 Jan;39(1):115-9. doi: 10.1016/j.arcmed.2007.07.006. Epub 2007 Oct 23. Arch Med Res. 2008. PMID: 18068004

6

Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit.

Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V. Frausova D, et al. Among authors: tesar v. Ren Fail. 2008;30(9):890-5. doi: 10.1080/08860220802353892. Ren Fail. 2008. PMID: 18925529 Free article.

7

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.

8

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Závada J, Kideryová L, Pytlík R, Hrusková Z, Tesar V. Závada J, et al. Among authors: tesar v. Rheumatology (Oxford). 2009 Oct;48(10):1197-201. doi: 10.1093/rheumatology/kep130. Epub 2009 Jun 9. Rheumatology (Oxford). 2009. PMID: 19509188

9

Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up.

Hruskova Z, Rihova Z, Mareckova H, Jancova E, Rysava R, Zavada J, Merta M, Löster T, Tesar V. Hruskova Z, et al. Among authors: tesar v. Arch Med Res. 2009 May;40(4):276-84. doi: 10.1016/j.arcmed.2009.04.001. Arch Med Res. 2009. PMID: 19608017

10

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.

Suppiah R, Flossman O, Mukhtyar C, Alberici F, Baslund B, Brown D, Hasan N, Holle J, Hruskova Z, Jayne D, Judge A, Little MA, Merkel PA, Palmisano A, Seo P, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R. Suppiah R, et al. Among authors: tesar v. Ann Rheum Dis. 2011 Jan;70(1):80-5. doi: 10.1136/ard.2009.122952. Epub 2010 Aug 24. Ann Rheum Dis. 2011. PMID: 20736392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters